Page last updated: 2024-09-03

vadimezan and Glioma

vadimezan has been researched along with Glioma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ching, LM; Connor, B; Guise, C; McGregor, A; Seyfoddin, V; Tijono, S; Yung, R	1
Ciesielski, MJ; Seshadri, M	1

Other Studies

2 other study(ies) available for vadimezan and Glioma

Article	Year
Efficacy against subcutaneous or intracranial murine GL261 gliomas in relation to the concentration of the vascular-disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), in the brain and plasma. Cancer chemotherapy and pharmacology, 2014, Volume: 73, Issue:3 Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Female; Glioma; Infusions, Subcutaneous; Lenalidomide; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Random Allocation; Thalidomide; Xanthones	2014
MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2009, Volume: 29, Issue:8 Topics: Angiogenesis Inhibitors; Animals; Brain Neoplasms; Cell Line, Tumor; Cerebral Angiography; Contrast Media; Glioma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Treatment Outcome; Xanthones; Xenograft Model Antitumor Assays	2009

Article

Year

Efficacy against subcutaneous or intracranial murine GL261 gliomas in relation to the concentration of the vascular-disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), in the brain and plasma.

Cancer chemotherapy and pharmacology, 2014, Volume: 73, Issue:3

Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Female; Glioma; Infusions, Subcutaneous; Lenalidomide; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Random Allocation; Thalidomide; Xanthones

2014

MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2009, Volume: 29, Issue:8

Topics: Angiogenesis Inhibitors; Animals; Brain Neoplasms; Cell Line, Tumor; Cerebral Angiography; Contrast Media; Glioma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Treatment Outcome; Xanthones; Xenograft Model Antitumor Assays

2009